Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

CIP/KIP proteins help stop cell division and support hair growth.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Hedychium spicatum has medicinal properties but needs more research for scientific validation and use.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Researchers found genes that control hair color and growth change before the visible coat color changes in snowshoe hares.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Early hair loss may indicate prostate issues.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Genetic marker rs12558842 strongly linked to male hair loss.

Suppressing certain hormones might help prevent prostate cancer.